In March I sold half my Gilead, believing that it was a little frothy and vulnerable in this year’s market. I’ve been concerned about the half I still own, given Trump’s tariffs and particularly the fact that Trump just took away India’s tariff exemption on its drug exports.
This is what I learned (ChatGPT, so do your own DD), which gives me some comfort:
________________________
Gilead Sciences primarily manufactures its pharmaceutical products within the United States, with significant facilities in California, including locations in Foster City, El Segundo, La Verne, Oceanside, and San Dimas. Additionally, Gilead operates a manufacturing site in Cork, Ireland. ([LinkedIn](https://www.linkedin.com/pulse/guide-gilead-map-selling-sciences-anthony-legere?utm_source=chatgpt.com))
Regarding international manufacturing, Gilead has engaged in licensing agreements with Indian pharmaceutical companies, allowing them to produce generic versions of its drugs for distribution in developing countries. These collaborations aim to enhance access to medications like HIV and hepatitis treatments in low-income regions. However, these India-manufactured generics are not intended for the U.S. market.([Gilead](https://www.gilead.com/news/news-details/2014/gilead-announces-generic-licensing-agreements-to-increase-access-to-hepatitis-c-treatments-in-developing-countries?utm_source=chatgpt.com))
Given this structure, Gilead's imports into the U.S. are minimal. Therefore, the company's exposure to President Trump's proposed tariffs on pharmaceutical imports is limited. Analysts have noted that Gilead faces lower risk compared to other pharmaceutical companies with substantial overseas manufacturing operations. ([dunkertoncoop.com](https://www.dunkertoncoop.com/news/story/31665799/these-2-buy-rated-dividend-stocks-could-be-next-in-line-for-a-trump-tariff-selloff-should-you-jump-ship-now?utm_source=chatgpt.com), [Barron's](https://www.barrons.com/articles/tariffs-ireland-pharma-stocks-beacc76b?utm_source=chatgpt.com))
___________________________ |
